Innovative Biologics
Anti-infective drug discovery and development company targeting microbes that produce pore-forming toxins.
Launch date
Employees
Market cap
-
Enterprise valuation
$400—600k (Dealroom.co estimates Oct 2007.)
Herndon Virginia (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
$1.7m | Grant | ||
$100k | Seed | ||
$200k | Early VC | ||
$1.8m | Grant | ||
$2.3m | Grant | ||
Total Funding | $6.1m |